SCWorx Corp. received formal notification from Nasdaq on September 2, 2026, that it no longer satisfies the minimum publicly held shares requirement for continued listing, having only 89,782 such shares. This deficiency stems from a 1-for-12 reverse stock split effective August 3, 2026, which reduced public float below the required 500,000 shares. Consequently, Nasdaq rules prevent SCWorx from being considered compliant with the minimum bid price requirement until it first regains compliance with the publicly held shares requirement and subsequently maintains a closing bid price of at least $1.00 for ten consecutive business days. The company also remains non-compliant with the market value of publicly held shares requirement, facing a compliance period expiring January 20, 2027. SCWorx intends to submit views to the Nasdaq Hearings Panel by September 9, 2026, and is evaluating alternatives such as issuing additional common stock to regain compliance, though no specific plan has been determined. SCWorx Corp. operates in the healthcare technology industry, providing software solutions for community health centers.

SCWorx Corp. filed a Certificate of Amendment to its Certificate of Incorporation with the State of Delaware on July 28, 2026, effecting a 1-for-12 reverse stock split of its common stock. The transaction becomes effective at 11:59 p.m. Eastern Time on August 3, 2026. Consequently, every twelve outstanding shares will combine into one share, reducing the expected outstanding count from approximately 1,066,918 to roughly 89,000 shares. Fractional shares are rounded up to whole shares. The company states this action aims to satisfy Nasdaq Hearings Panel conditions regarding the minimum bid price requirement by August 28, 2026. However, the split reduces publicly held shares below Nasdaq's 500,000 share minimum and does not address a separate deficiency in market value of publicly held shares. SCWorx Corp. operates in the healthcare information technology sector.

SCWorx Corp. received a partial compliance letter from the Nasdaq Hearings Panel confirming it met the first condition of its plan to regain listing on The Nasdaq Capital Market, which required shareholder approval for a reverse stock split by July 22, 2026. The company must now effectuate the reverse stock split by August 3, 2026, and demonstrate a closing bid price of at least $1.00 per share for twenty consecutive trading days by August 28, 2026. SCWorx operates in the healthcare technology industry, providing data normalization and supply chain solutions.

SCWorx Corp. received a notice from Nasdaq on July 24, 2026, indicating that its Market Value of Publicly Held Shares (MVPHS) failed to maintain the minimum requirement of $1 million for the last 30 consecutive business days ending July 23, 2026. The company has been granted an 180-day compliance period through January 20, 2027, during which it must demonstrate MVPHS of at least $1 million for ten consecutive business days to regain listing standards. SCWorx is currently evaluating alternatives to satisfy these requirements but has not yet determined a specific course of action. Failure to comply could result in delisting from Nasdaq, though the company retains the right to appeal such a determination. SCWorx Corp. operates in the healthcare technology industry, providing software solutions for senior living communities.

SCWorx Corp. held its 2026 Annual Meeting of Stockholders on July 22, 2026. Shareholders elected Timothy A. Hannibal, Troy Kirchenbauer, Vincent Matozzo, and Michael Burke to the Board of Directors. The non-binding advisory vote on executive compensation failed, receiving 112,820 votes in favor and 128,981 against. Astra Audit & Advisory, LLC was ratified as the independent auditor for the 2026 fiscal year. Additionally, stockholders approved a proposal to amend the certificate of incorporation to allow a reverse stock split with a ratio between 1-for-1.5 and 1-for-20 to maintain Nasdaq compliance, receiving 289,591 votes in favor and 183,285 against. SCWorx Corp. is a technology company focused on diagnostic solutions.

Nasdaq's Hearings Panel granted SCWorx Corp. a request to continue its common stock listing following a trading suspension on April 14, 2026, due to failure to meet the $1.00 minimum bid price requirement. To reinstate trading, the company must obtain shareholder approval for a reverse stock split by July 22, 2026, execute the split by August 3, 2026, and maintain a closing bid price of at least $1.00 for 20 consecutive trading days by August 28, 2026. Failure to meet these conditions will result in delisting from Nasdaq. SCWorx Corp. is currently quoted on the OTCQB Market. The company operates in the technology and healthcare services sector.